SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
EXAGEN INC.
@XGN_InsiderForm 4 Filing: McKhann Chas Acquires (Grant) shares of $XGN
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
EXAGEN INC.
Ticker: $XGN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-09
Shares: 37,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, McKhann Chas, holds the title of Director at EXAGEN INC..
On 2026-06-09, the insider transacted 37,500 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
McKhann Chas (Director) was granted $0 of $XGN
Post-Transaction Position: 45,000 shares
SEC Accession No: 0001274737-26-000038 (CIK: 1631746)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.